江汉大学学报（自然科学版）Issue(3)：90-92,3.
舒洛地特治疗早期糖尿病肾病白蛋白尿
Treatment of Sulodexide on Albuminuria in Early Diabetic Nephropathy
熊萦哲1
作者信息
- 1. 武汉市江夏区第一人民医院 内3科，湖北 武汉 430200
- 折叠
摘要
Abstract
Objective To study the clinical effect of Sulodexide on albuminuria in early diabetic nephropathy. Methods 65 cases of patients with early diabetic nephropathy were randomly divid⁃ed to a control group including 30 cases and a treatment group including 35 cases. Both groups have the treatment 8 weeks. The control group orally take Losartan 50 mg/d for 4 weeks. The treatment group on the basis of normal treatment(Losartan potassium 50 mg,one time/d),adds Sulodexide 600 LSU,qd,iv ,one time/d,after 2 weeks,changes to use Sulodexide tablet 200 mg/d for 6 weeks (totally 8 weeks). Results After treatment,B2-MG,BUN,CREA and 24-hour urinary protein is significantly lower than that before treatment for both groups(P<0. 05 or P<0. 01). These indexes of treatment group are better than those of control group. Conclusion Sulodexide can relieve albu⁃minuria effectively in early diabetic nephropathy.关键词
舒洛地特/24 h尿蛋白定量/糖尿病肾病Key words
Sulodexide/24-hour urinary protein/early diabetic nephropathy分类
医药卫生引用本文复制引用
熊萦哲..舒洛地特治疗早期糖尿病肾病白蛋白尿[J].江汉大学学报（自然科学版）,2014,(3):90-92,3.
